Explore our FDA-approved Shield™ blood-based screening test. Discover how our advanced technology detects cancer early, when it's most treatable.

The Shield™ test is a qualitative, in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Shield Blood Collection Kit.

The Shield™ test is a qualitative, in vitro diagnostic test indicated to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Shield Blood Collection Kit.

What is the Shield test and is it right for you? The Shield test is a qualitative, in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from...

Explore the innovative Shield™ blood test by Guardant Health, designed to identify colon cancer cancer at its earliest stages.

Oct 11, 2024 · Called Shield, the test looks for the presence of specific changes to DNA floating freely in the blood, called cell-free DNA, that indicate the presence of a tumor or precancerous growths in the …

The Shield blood test* uses a multimodal approach, integrating genomics, epigenomics and proteomics, to achieve high sensitivity and specificity in detecting early signs of colorectal cancer in average-risk …

e screening methods. Shield is available for eligible individuals by prescription through a healthcare provider and mee #2 CRC is the second leading cause of cancer-related deaths.

Guardant Health Shield is a proprietary blood test designed to identify genomic and epigenomic alterations in cell‐free DNA and proteomic changes in plasma for early detection of colon...

The Shield™ test is a qualitative, in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Shield Blood Collection Kit.